Complement in health and disease

被引:167
|
作者
Carroll, Maria V. [1 ]
Sim, Robert B. [1 ]
机构
[1] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England
关键词
Complement; Innate immunity; Blood plasma; Collectins; Inflammation; Phagocytosis; Opsonisation; Autoimmunity; Infection; Disease; MANNOSE-BINDING PROTEIN; PATTERN-RECOGNITION MOLECULES; SYSTEMIC-LUPUS-ERYTHEMATOSUS; HUMAN FACTOR-H; LECTIN PATHWAY ACTIVATION; GUINEA-PIG SERUM; L-FICOLIN; 1ST COMPONENT; ALTERNATIVE-PATHWAY; SERINE PROTEASES;
D O I
10.1016/j.addr.2011.06.005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The complement system consists of about 35-40 proteins and glycoproteins present in blood plasma or on cell surfaces. Its main biological function is to recognise "foreign" particles and macromolecules, and to promote their elimination either by opsonisation or lysis. Although historically complement has been studied as a system for immune defence against bacteria, it has an important homeostatic role in which it recognises damaged or altered "self" components. Thus complement has major roles in both immune defence against microorganisms, and in clearance of damaged or "used" host components. Since complement proteins opsonise or lyse cells, complement can damage healthy host cells and tissues. The system is regulated by many endogenous regulatory proteins. Regulation is sometimes imperfect and both too much and too little complement activation is associated with many diseases. Excessive or inappropriate activation can cause tissue damage in diseases such as rheumatoid arthritis, age-related macular degeneration (AMD), multiple sclerosis, ischemia-reperfusion injury (e.g. ischemic stroke). Insufficient complement activity is associated with susceptibility to infection (mainly bacterial) and development of autoimmune disease, like SLE (systemic lupus erythematosus). (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:965 / 975
页数:11
相关论文
共 50 条
  • [31] COMPLEMENT DEFICIENCY AND DISEASE
    WALPORT, MJ
    BRITISH JOURNAL OF RHEUMATOLOGY, 1993, 32 (04): : 269 - 273
  • [32] COMPLEMENT DEFICIENCY AND DISEASE
    CHARLESWORTH, JA
    PUSSELL, BA
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1982, 12 (06): : 649 - 655
  • [33] COMPLEMENT ACTIVATION AND DISEASE
    不详
    BMJ-BRITISH MEDICAL JOURNAL, 1976, 1 (6007): : 416 - 416
  • [34] COMPLEMENT DEFICIENCY AND DISEASE
    MORGAN, BP
    WALPORT, MJ
    IMMUNOLOGY TODAY, 1991, 12 (09): : 301 - 306
  • [35] Complement deficiency and disease
    Unsworth, D. J.
    JOURNAL OF CLINICAL PATHOLOGY, 2008, 61 (09) : 1013 - 1017
  • [36] Complement and renal disease
    Trouw, LA
    Seelen, MA
    Daha, MR
    MOLECULAR IMMUNOLOGY, 2003, 40 (2-4) : 125 - 134
  • [37] Complement in renal disease
    Charlesworth, JA
    Peake, PW
    Pussell, BA
    Erlich, JH
    NEPHROLOGY, 2001, 6 (04) : 145 - 154
  • [38] Complement in human disease
    Wurzner, R
    Dierich, MP
    IMMUNOLOGY TODAY, 1997, 18 (10): : 460 - 463
  • [39] COMPLEMENT AND DISEASE - A REVIEW
    ADINOLFI, M
    ZENTHON, J
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1982, 75 (02) : 121 - 123
  • [40] Complement in Human Disease
    Flierl, Michael A.
    Rittirsch, Daniel
    Huber-Lang, Markus S.
    Stahel, Philip F.
    CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2013,